Form 4: Compass Pathways Director Malievskaia Sells Shares Under 10b5-1 Trading Plan

Ekaterina Malievskaia, a director at Compass Pathways plc, executed sales of ordinary shares under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On February 23 and 26, 2024, Ekaterina Malievskaia, a director of Compass Pathways plc, sold ordinary shares of the company.
• The sales were executed under a Rule 10b5-1 trading plan adopted on August 23, 2023.
• On February 23, 2024, 11,862 shares were sold at a weighted average price of $10.0594, with prices ranging from $9.83 to $10.23.
• On February 23, 2024, 11,863 shares held by her spouse were sold at a weighted average price of $10.0594, with prices ranging from $9.83 to $10.23.
• On February 26, 2024, 17,765 shares were sold at a weighted average price of $10.4476, with prices ranging from $10.23 to $10.735.
• On February 26, 2024, 17,765 shares held by her spouse were sold at a weighted average price of $10.4476, with prices ranging from $10.23 to $10.735.
• Following these transactions, Malievskaia directly owns 4,092,573 shares and her spouse indirectly owns 4,094,847 shares.
• Malievskaia and her spouse disclaim beneficial ownership of each other's shares.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to insider trading. It doesn't inherently convey positive or negative sentiment, as it simply reports transactions.

Industry Context

Sales by insiders are a common occurrence, but are closely watched by investors for signals about a company's prospects. The use of a 10b5-1 trading plan suggests the sales were pre-planned and intended to avoid accusations of trading on inside information.

Stakeholder Impact

• Shareholders may interpret insider sales as a lack of confidence in the company's future prospects, although sales under a 10b5-1 plan are generally viewed as less concerning.

Key Dates